Literature DB >> 17444806

Comparative analysis of prednisolone acetate suspensions.

Calvin W Roberts1, Peter L Nelson.   

Abstract

PURPOSE: The aim of this study was to determine differences in particle size between three prednisolone acetate suspensions: Pred Forte, EconoPred Plus, and generic prednisolone acetate 1%.
SETTING: This study employed the setting of a laboratory evaluation.
METHODS: Qualitative assessment of sedimentation rate as a function of particle size was the method employed for this study. Samples of the three products were taken from the top of the suspensions at 0 and 6 h and then at 12-h intervals from 12 to 72 h. At 72 h, a sample was pulled from the bottom of each suspension.
RESULTS: Particle size in aliquots removed from the top of the suspensions steadily decreased over time. In the Pred Forte sample, results for 72 h (bottom) were consistent with T = 0 h results. In the generic and EconoPred Plus lots, the T = 72 h (bottom) results exceeded the T = 0 h results, suggesting a tendency for these particles to agglomerate more readily.
CONCLUSIONS: The prednisolone particles in Pred Forte were smaller and more uniform at all time points, allowing them to stay in suspension longer. This may result in greater homogeneity between doses and increased ocular bioavailability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444806     DOI: 10.1089/jop.2006.0070

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  3 in total

1.  Are generic topical prostanoids the way forward in the care of glaucoma patients? - Yes.

Authors:  L C Titcomb
Journal:  Eye (Lond)       Date:  2013-06-28       Impact factor: 3.775

2.  Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%).

Authors:  Zora T Marlowe; Stephen R Davio
Journal:  Clin Ophthalmol       Date:  2013-12-10

3.  Tear Film Pharmacokinetics and Systemic Absorption Following Topical Administration of 1% Prednisolone Acetate Ophthalmic Suspension in Dogs.

Authors:  Lionel Sebbag; Nicolette S Kirner; Larry W Wulf; Jonathan P Mochel
Journal:  Front Vet Sci       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.